Endothelial expression of human ABCA1 in mice increases plasma HDL cholesterol and reduces diet-induced atherosclerosis

Journal of Lipid Research

Volumn 53, Issue 1, 2012, Pages 158-167

  Vaisman, Boris L ^a   Demosky, Stephen J ^a   Stonik, John A ^a   Ghias, Mona ^a   Knapper, Cathy L ^a   Sampson, Maureen L ^b   Dai, Cuilian ^a   Levine, Stewart J ^a   Remaley, Alan T ^a  

^a NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

ATP binding cassette transporter A1; Cholesterol efflux; Endothelial cells; High density lipoprotein; Reverse cholesterol transport

Indexed keywords

APOLIPOPROTEIN A1; ENDOTHELIAL NITRIC OXIDE SYNTHASE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL;

ABCA1 GENE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; AORTA; AORTA ATHEROSCLEROSIS; APOE GENE; APOPTOSIS; ARTICLE; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL DIET; CHOLESTEROL TRANSPORT; CONTROLLED STUDY; ENDOTHELIUM CELL; GENE; GENE EXPRESSION; HIGH DENSITY LIPOPROTEIN CHOLESTEROL BLOOD LEVEL; INFLAMMATION; LIPID DIET; MOUSE; NONHUMAN; PERITONEUM MACROPHAGE; PRIORITY JOURNAL; TRANSGENIC MOUSE;

ANIMALS; AORTA; APOLIPOPROTEIN A-I; ATHEROSCLEROSIS; ATP-BINDING CASSETTE TRANSPORTERS; CHOLESTEROL, DIETARY; CHOLESTEROL, HDL; DIETARY FATS; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; MICE; MICE, TRANSGENIC;

EID: 84455188820     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/jlr.M018713     Document Type: Article

References (64)

1. Jaffe, E. A. 1987. Cell biology of endothelial cells. Hum. Pathol. 18: 234-239. (Pubitemid 17051255)
2. Aird, W. C. 2007. Phenotypic heterogeneity of the endothelium. I. Structure, function, and mechanisms. Circ. Res. 100: 158-173. (Pubitemid 46208717)
3. Rader, D. J., and K. A. Dugi. 2000. The endothelium and lipoproteins: insights from recent cell biology and animal studies. Semin. Thromb. Hemost. 26: 521-528.
4. Sitia, S., L. Tomasoni, F. Atzeni, G. Ambrosio, C. Cordiano, A. Catapano, S. Tramontana, F. Perticone, P. Naccarato, P. Camici, et al. 2010. From endothelial dysfunction to atherosclerosis. Autoimmun. Rev. 9: 830-834.
5. Hulsmans, M., and P. Holvoet. 2010. The vicious circle between oxidative stress and inflammation in atherosclerosis. J. Cell. Mol. Med. 14: 70-78.
6. Adachi, H., and M. Tsujimoto. 2006. Endothelial scavenger receptors. Prog. Lipid Res. 45: 379-404.
7. Hasham, S. N., and S. Pillarisetti. 2006. Vascular lipases, inflammation and atherosclerosis. Clin. Chim. Acta. 372: 179-183. (Pubitemid 44286780)
8. Glomset, J. A. 1968. The plasma lecithins:cholesterol acyltransferase reaction. J. Lipid Res. 9: 155-167.
9. Rader, D. J., E. T. Alexander, G. L. Weibel, J. Billheimer, and G. H. Rothblat. 2009. The role of reverse cholesterol transport in animals and humans and relationship to atherosclerosis. J. Lipid Res. 50: S189-S194.
10. McNeish, J., R. J. Aiello, D. Guyot, T. Turi, C. Gabel, C. Aldinger, K. L. Hoppe, M. L. Roach, L. J. Royer, J. de Wet, et al. 2000. High density lipoprotein deficiency and foam cell accumulation in mice with targeted disruption of ATP-binding cassette transporter-1. Proc. Natl. Acad. Sci. USA. 97: 4245-4250. (Pubitemid 30226118)
11. Vaisman, B. L., G. Lambert, M. Amar, C. Joyce, T. Ito, R. D. Shamburek, W. J. Cain, J. Fruchart-Najib, E. D. Neufeld, A. T. Remaley, et al. 2001. ABCA1 overexpression leads to hyperalphalipoproteinemia and increased biliary cholesterol excretion in transgenic mice. J. Clin. Invest. 108: 303-309. (Pubitemid 32656254)
12. Singaraja, R. R., V. Bocher, E. R. James, S. M. Clee, L. H. Zhang, B. R. Leavitt, B. Tan, A. Brooks-Wilson, A. Kwok, N. Bissada, et al. 2001. Human ABCA1 BAC transgenic mice show increased high density lipoprotein cholesterol and ApoAI-dependent efflux stimulated by an internal promoter containing liver X receptor response elements in intron 1. J. Biol. Chem. 276: 33969-33979.
13. Singaraja, R. R., M. Van Eck, N. Bissada, F. Zimetti, H. L. Collins, R. B. Hildebrand, A. Hayden, L. R. Brunham, M. H. Kang, J. C. Fruchart, et al. 2006. Both hepatic and extrahepatic ABCA1 have discrete and essential functions in the maintenance of plasma high-density lipoprotein cholesterol levels in vivo. Circulation. 114: 1301-1309. (Pubitemid 44402056)
14. Brunham, L. R., J. K. Kruit, J. Iqbal, C. Fievet, J. M. Timmins, T. D. Pape, B. A. Coburn, N. Bissada, B. Staels, A. K. Groen, et al. 2006. Intestinal ABCA1 directly contributes to HDL biogenesis in vivo. J. Clin. Invest. 116: 1052-1062.
15. Rye, K. A., and P. J. Barter. 2004. Formation and metabolism of prebeta-migrating, lipid-poor apolipoprotein A-I. Arterioscler. Thromb. Vasc. Biol. 24: 421-428.
16. Hoekstra, M., J. K. Kruijt, M. Van Eck, and T. J. Van Berkel. 2003. Specific gene expression of ATP-binding cassette transporters and nuclear hormone receptors in rat liver parenchymal, endothelial, and Kupffer cells. J. Biol. Chem. 278: 25448-25453. (Pubitemid 36835295)
17. Hassan, H. H., M. Denis, L. Krimbou, M. Marcil, and J. Genest. 2006. Cellular cholesterol homeostasis in vascular endothelial cells. Can. J. Cardiol. 22(Suppl. B): 35B-40B. (Pubitemid 44963570)
18. von Eckardstein, A., and L. Rohrer. 2009. Transendothelial lipoprotein transport and regulation of endothelial permeability and integrity by lipoproteins. Curr. Opin. Lipidol. 20: 197-205.
19. Terasaka, N., S. Yu, L. Yvan-Charvet, N. Wang, N. Mzhavia, R. Langlois, T. Pagler, R. Li, C. L. Welch, I. J. Goldberg, et al. 2008. ABCG1 and HDL protect against endothelial dysfunction in mice fed a high-cholesterol diet. J. Clin. Invest. 118: 3701-3713.
20. Cavelier, C., L. Rohrer, and A. von Eckardstein. 2006. ATP-Binding cassette transporter A1 modulates apolipoprotein A-I transcytosis through aortic endothelial cells. Circ. Res. 99: 1060-1066. (Pubitemid 44729929)
21. Rohrer, L., P. M. Ohnsorg, M. Lehner, F. Landolt, F. Rinninger, and A. von Eckardstein. 2009. High-density lipoprotein transport through aortic endothelial cells involves scavenger receptor BI and ATP-binding cassette transporter G1. Circ. Res. 104: 1142-1150
22. Schlaeger, T. M., S. Bartunkova, J. A. Lawitts, G. Teichmann, W. Risau, U. Deutsch, and T. N. Sato. 1997. Uniform vascular-endothelial-cell-specific gene expression in both embryonic and adult transgenic mice. Proc. Natl. Acad. Sci. USA. 94: 3058-3063. (Pubitemid 27157263)
23. Teng, P. I., M. R. Dichiara, L. G. Komuves, K. Abe, T. Quertermous, and J. N. Topper. 2002. Inducible and selective transgene expression in murine vascular endothelium. Physiol. Genomics. 11: 99-107.
24. Schmittgen, T. D., and K. J. Livak. 2008. Analyzing real-time PCR data by the comparative C(T) method. Nat. Protoc. 3: 1101-1108. (Pubitemid 351818697)
25. Sekine, Y., S. J. Demosky, J. A. Stonik, Y. Furuya, H. Koike, K. Suzuki, and A. T. Remaley. 2010. High-density lipoprotein induces proliferation and migration of human prostate androgen-independent cancer cells by an ABCA1-dependent mechanism. Mol. Cancer Res. 8: 1284-1294.
26. Basso, F., M. J. Amar, E. M. Wagner, B. Vaisman, B. Paigen, S. Santamarina-Fojo, and A. T. Remaley. 2006. Enhanced ABCG1 expression increases atherosclerosis in LDLr-KO mice on a western diet. Biochem. Biophys. Res. Commun. 351: 398-404. (Pubitemid 44679753)
27. Vaisman, B. L., H. G. Klein, M. Rouis, A. M. Berard, M. R. Kindt, G. D. Talley, S. M. Meyn, R. F. Hoyt, Jr., S. M. Marcovina, J. J. Albers, et al. 1995. Overexpression of human lecithin cholesterol acyltransferase leads to hyperalphalipoproteinemia in transgenic mice. J. Biol. Chem. 270: 12269-12275.
28. Goldstein, J. L., Y. K. Ho, S. K. Basu, and M. S. Brown. 1979. Binding site on macrophages that mediates uptake and degradation of acetylated low density lipoprotein, producing massive cholesterol deposition. Proc. Natl. Acad. Sci. USA. 76: 333-337. (Pubitemid 9110191)
29. Shi, W., M. E. Haberland, M. L. Jien, D. M. Shih, and A. J. Lusis. 2000. Endothelial responses to oxidized lipoproteins determine genetic susceptibility to atherosclerosis in mice. Circulation. 102: 75-81. (Pubitemid 30430556)
30. Suh, S. H., R. Vennekens, V. G. Manolopoulos, M. Freichel, U. Schweig, J. Prenen, V. Flockerzi, G. Droogmans, and B. Nilius. 1999. Characterisation of explanted endothelial cells from mouse aorta: electrophysiology and Ca2+ signalling. Pflugers Arch. 438: 612-620. (Pubitemid 29454975)
31. Lim, Y. C., G. Garcia-Cardena, J. R. Allport, M. Zervoglos, A. J. Connolly, M. A. Gimbrone, Jr., and F. W. Luscinskas. 2003. Heterogeneity of endothelial cells from different organ sites in T-cell subset recruitment. Am. J. Pathol. 162: 1591-1601. (Pubitemid 36512842)
32. Voyta, J. C., D. P. Via, C. E. Butterfield, and B. R. Zetter. 1984. Identification and isolation of endothelial cells based on their increased uptake of acetylated-low density lipoprotein. J. Cell Biol. 99:2034-2040. (Pubitemid 15181864)
33. Oram, J. F. 1986. Receptor-mediated transport of cholesterol between cultured cells and high-density lipoproteins. Methods Enzymol. 129: 645-659. (Pubitemid 16055973)
34. Koni, P. A., S. K. Joshi, U. A. Temann, D. Olson, L. Burkly, and R. A. Flavell. 2001. Conditional vascular cell adhesion molecule 1 deletion in mice: impaired lymphocyte migration to bone marrow. J. Exp. Med. 193: 741-754.
35. Möckel, B., H. Zinke, R. Flach, B. Weiss, H. Weiler-Guttler, and H. G. Gassen. 1994. Expression of apolipoprotein A-I in porcine brain endothelium in vitro. J. Neurochem. 62: 788-798. (Pubitemid 24041351)
36. Panzenboeck, U., Z. Balazs, A. Sovic, A. Hrzenjak, S. Levak-Frank, A. Wintersperger, E. Malle, and W. Sattler. 2002. ABCA1 and scavenger receptor class B, type I, are modulators of reverse sterol transport at an in vitro blood-brain barrier constituted of porcine brain capillary endothelial cells. J. Biol. Chem. 277: 42781-42789. (Pubitemid 35285652)
37. Adini, I., I. Rabinovitz, J. F. Sun, G. C. Prendergast, and L. E. Benjamin. 2003. RhoB controls Akt trafficking and stage-specific survival of endothelial cells during vascular development. Genes Dev. 17: 2721-2732. (Pubitemid 37363076)
38. Maruyama, I. 1998. Biology of endothelium. Lupus. 7 (Suppl 2) : S41-S43. (Pubitemid 28484579)
39. Chatterjee, A., S. M. Black, and J. D. Catravas. 2008. Endothelial nitric oxide (NO) and its pathophysiologic regulation. Vascul. Pharmacol. 49: 134-140.
40. Earnshaw, W. C., L. M. Martins, and S. H. Kaufmann. 1999. Mammalian caspases: structure, activation, substrates, and functions during apoptosis. Annu. Rev. Biochem. 68: 383-424. (Pubitemid 29449198)
41. Hur, G. M., Y. S. Kim, M. Won, S. Choksi, and Z. G. Liu. 2006. The death domain kinase RIP has an important role in DNA damage-induced, p53-independent cell death. J. Biol. Chem. 281: 25011-25017 (Pubitemid 44401889)
42. Zauli, G., and P. Secchiero. 2006. The role of the TRAIL/TRAIL receptors system in hematopoiesis and endothelial cell biology. Cytokine Growth Factor Rev. 17: 245-257. (Pubitemid 44038614)
43. Davies, P. F. 2008. Endothelial transcriptome profiles in vivo in complex arterial flow fields. Ann. Biomed. Eng. 36: 563-570.
44. Tang, C. R., and J. F. Oram. 2009. The cell cholesterol exporter ABCA1 as a protector from cardiovascular disease and diabetes. Biochim. Biophys. Acta. 1791: 563-572.
45. Joyce, C. W., M. J. Amar, G. Lambert, B. L. Vaisman, B. Paigen, J. Najib-Fruchart, R. F. Hoyt, Jr., E. D. Neufeld, A. T. Remaley, D. S. Fredrickson, et al. 2002. The ATP binding cassette transporter A1 (ABCA1) modulates the development of aortic atherosclerosis in C57BL/6 and apoE-knockout mice. Proc. Natl. Acad. Sci. USA. 99: 407-412. (Pubitemid 34060374)
46. Kypreos, K. E., and V. I. Zannis. 2007. Pathway of biogenesis of apolipoprotein E-containing HDL in vivo with the participation of ABCA1 and LCAT. Biochem. J. 403: 359-367. (Pubitemid 46596593)
47. Vedhachalam, C., V. Narayanaswami, N. Neto, T. M. Forte, M. C. Phillips, S. Lund-Katz, and J. K. Bielicki. 2007. The C-terminal lipid-binding domain of apolipoprotein E is a highly efficient mediator of ABCA1-dependent cholesterol efflux that promotes the assembly of high-density lipoproteins. Biochemistry. 46: 2583-2593. (Pubitemid 46417902)
48. Mineo, C., H. Deguchi, J. H. Griffin, and P. W. Shaul. 2006. Endothelial and antithrombotic actions of HDL. Circ. Res. 98: 1352-1364. (Pubitemid 43948059)
49. Shaul, P. W., and C. Mineo. 2004. HDL action on the vascular wall: is the answer NO? J. Clin. Invest. 113: 509-513. (Pubitemid 38542499)
50. Shaul, P. W. 2003. Endothelial nitric oxide synthase, caveolae and the development of atherosclerosis. J. Physiol. 547: 21-33. (Pubitemid 36285158)
51. Nofer, J. R., M. van der Giet, M. Tolle, I. Wolinska, K. von Wnuck Lipinski, H. A. Baba, U. J. Tietge, A. Godecke, I. Ishii, B. Kleuser, et al. 2004. HDL induces NO-dependent vasorelaxation via the lysophospholipid receptor S1P3. J. Clin. Invest. 113: 569-581. (Pubitemid 38542506)
52. DiStasi, M. R., and K. Ley. 2009. Opening the flood-gates: how neutrophil-endothelial interactions regulate permeability. Trends Immunol. 30: 547-556.
53. Woodfin, A., M. B. Voisin, and S. Nourshargh. 2007. PECAM-1: a multi-functional molecule in inflammation and vascular biology. Arterioscler. Thromb. Vasc. Biol. 27: 2514-2523. (Pubitemid 350158900)
54. Quéméneur, T., F. Martin-Nizard, A. Kandoussi, X. Kyndt, P. Vanhille, E. Hachulla, P. Y. Hatron, J. C. Fruchart, P. Duriez, and M. Lambert. 2007. PON1, a new biomarker of cardiovascular disease, is low in patients with systemic vasculitis. Semin. Arthritis Rheum. 37: 149-155. (Pubitemid 350153648)
55. Chiang, A. N., B. Hwang, G. C. Shaw, B. C. Lee, J. H. Lu, C. C. Meng, and P. Chou. 1997. Changes in plasma levels of lipids and lipoprotein composition in patients with Kawasaki disease. Clin. Chim. Acta. 260: 15-26. (Pubitemid 27136409)
56. Cheung, Y. F., T. C. Yung, S. C. Tam, M. H. Ho, and A. K. Chau. 2004. Novel and traditional cardiovascular risk factors in children after Kawasaki disease: implications for premature atherosclerosis. J. Am. Coll. Cardiol. 43: 120-124.
57. Musabak, U., O. Baylan, T. Cetin, Z. Yesilova, A. Sengul, K. Saglam, A. Inal, and I. H. Kocar. 2005. Lipid profile and anticardiolipin antibodies in Behcet's disease. Arch. Med. Res. 36: 387-392. (Pubitemid 40798394)
58. Yang, G., R. Lucas, R. Caldwell, L. Yao, M. J. Romero, and R. W. Caldwell. 2010. Novel mechanisms of endothelial dysfunction in diabetes. J. Cardiovasc. Dis. Res. 1: 59-63.
59. Schulz, E., T. Gori, and T. Munzel. 2011. Oxidative stress and endothelial dysfunction in hypertension. Hypertens. Res. 34: 665-673.
60. Vergès, B. 2009. Lipid modification in type 2 diabetes: the role of LDL and HDL. Fundam. Clin. Pharmacol. 23: 681-685.
61. Zicha, J., J. Kunes, and M. A. Devynck. 1999. Abnormalities of membrane function and lipid metabolism in hypertension: a review. Am. J. Hypertens. 12: 315-331. (Pubitemid 29147359)
62. Haas, M. J., and A. D. Mooradian. 2010. Regulation of high-density lipoprotein by inflammatory cytokines: establishing links between immune dysfunction and cardiovascular disease. Diabetes Metab. Res. Rev. 26: 90-99.
63. Vohra, R. S., J. E. Murphy, J. H. Walker, S. Ponnambalam, and S. Homer-Vanniasinkam. 2006. Atherosclerosis and the Lectin-like OXidized low-density lipoprotein scavenger receptor. Trends Cardiovasc. Med. 16: 60-64. (Pubitemid 43214528)
64. Fan, J., and T. Watanabe. 2003. Inflammatory reactions in the pathogenesis of atherosclerosis. J. Atheroscler. Thromb. 10: 63-71.